BACKGROUND: Matrix Gla protein (MGP) is one of the important proteins inhibiting vascular calcification (VC). Single nucleotide polymorphisms (SNPs) located in the promoter and coding regions of the MGP gene affect the transcriptional activity. In this study, we investigated the relationship between the SNPs and progression of VC in patients undergoing maintenance hemodialysis (MHD). METHODS: This was a retrospective, longitudinal cohort study of 134 MHD patients whose VC could be followed by multi-detector computed tomography (MDCT) examinations. MGP-SNPs (T-138C, rs1800802 and G-7A, rs1800801) were determined. The progression speed of VC was examined by plotting the abdominal aortic calcium volume scores. RESULTS: The progression speed of VC of patients with the CC genotype of T-138C was significantly slower than that of patients with the CT or TT genotype. Multiple regression analysis showed that CT/TT genotype, greater age at the beginning of MHD, male sex, high levels of calcium × phosphate, low levels of high-density lipoprotein cholesterol, high levels of low-density lipoprotein cholesterol, low levels of ferritin and non-use of angiotensin II receptor blockers were significantly associated with progression of VC. CONCLUSIONS: The MGP-138CC genotype may be associated with slower progression of VC in MHD patients. The genotype of the MGP gene will be a genomic biomarker that is predictive of VC progression.
BACKGROUND:Matrix Gla protein (MGP) is one of the important proteins inhibiting vascular calcification (VC). Single nucleotide polymorphisms (SNPs) located in the promoter and coding regions of the MGP gene affect the transcriptional activity. In this study, we investigated the relationship between the SNPs and progression of VC in patients undergoing maintenance hemodialysis (MHD). METHODS: This was a retrospective, longitudinal cohort study of 134 MHD patients whose VC could be followed by multi-detector computed tomography (MDCT) examinations. MGP-SNPs (T-138C, rs1800802 and G-7A, rs1800801) were determined. The progression speed of VC was examined by plotting the abdominal aortic calcium volume scores. RESULTS: The progression speed of VC of patients with the CC genotype of T-138C was significantly slower than that of patients with the CT or TT genotype. Multiple regression analysis showed that CT/TT genotype, greater age at the beginning of MHD, male sex, high levels of calcium × phosphate, low levels of high-density lipoprotein cholesterol, high levels of low-density lipoprotein cholesterol, low levels of ferritin and non-use of angiotensin II receptor blockers were significantly associated with progression of VC. CONCLUSIONS: The MGP-138CC genotype may be associated with slower progression of VC in MHD patients. The genotype of the MGP gene will be a genomic biomarker that is predictive of VC progression.
Authors: L A Braam; P Dissel; B L Gijsbers; H M Spronk; K Hamulyák; B A Soute; W Debie; C Vermeer Journal: Arterioscler Thromb Vasc Biol Date: 2000-05 Impact factor: 8.311
Authors: P W Wilson; L I Kauppila; C J O'Donnell; D P Kiel; M Hannan; J M Polak; L A Cupples Journal: Circulation Date: 2001-03-20 Impact factor: 29.690
Authors: Geoffrey A Block; David M Spiegel; James Ehrlich; Ravindra Mehta; Jill Lindbergh; Albert Dreisbach; Paolo Raggi Journal: Kidney Int Date: 2005-10 Impact factor: 10.612
Authors: Leon J Schurgers; Kirsten J F Teunissen; Marjo H J Knapen; Piet Geusens; Desiree van der Heijde; Martijn Kwaijtaal; Rob van Diest; Markus Ketteler; Cees Vermeer Journal: Clin Chim Acta Date: 2005-01 Impact factor: 3.786
Authors: Michael D Crosier; Sarah L Booth; Inga Peter; Bess Dawson-Hughes; Paul A Price; Christopher J O'Donnell; Udo Hoffmann; Matthew K Williamson; Jose M Ordovas Journal: J Nutr Sci Vitaminol (Tokyo) Date: 2009-02 Impact factor: 2.000
Authors: Craig R Walsh; L Adrienne Cupples; Daniel Levy; Douglas P Kiel; Marian Hannan; Peter W F Wilson; Christopher J O'Donnell Journal: Am Heart J Date: 2002-10 Impact factor: 4.749
Authors: O Mayer; J Seidlerová; P Wohlfahrt; J Filipovský; J Vaněk; R Cífková; J Windrichová; O Topolčan; M H J Knapen; N E A Drummen; C Vermeer Journal: J Hum Hypertens Date: 2015-05-28 Impact factor: 3.012
Authors: Valerie N Babinsky; Fadil M Hannan; Sonia C Youhanna; Céline Maréchal; Michel Jadoul; Olivier Devuyst; Rajesh V Thakker Journal: PLoS One Date: 2015-03-18 Impact factor: 3.240